Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruikun Du

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
ACS Pharmacology & Translational Science|December 14, 2023
Identification of the Imidazo[1,2-<i>a</i>]pyrazine Derivative <b>A4</b> as a Potential Influenza Virus Nucleoprotein InhibitorPing Li, Han Ju, Yihong Xing, et al.
Experimental and Therapeutic Medicine|November 12, 2020
Selection and validation of optimal endogenous reference genes for analysis of quantitative PCR in four tissues pathologically associated with Kidney-yang deficiency syndrome following influenza A infectionYepei Fu, Jia Yang, Shanshan Fan, et al.
Cell & Bioscience|February 28, 2021
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteasesZinuo Chen, Qinghua Cui, Laura Cooper, et al.
Frontiers in Microbiology|April 8, 2020
Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase InhibitorsPing Li, Ruikun Du, Yanyan Wang, et al.
Antiviral Research|March 12, 2025
Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agentRuikun Du, Jiawen Sun, Chunlei Zhang, et al.
Journal of Medical Virology|August 28, 2023
Licochalcone A plays dual antiviral roles by inhibiting RSV and protecting against host damageZhongyuan Li, Baohong Li, Zinuo Chen, et al.
Journal of Medical Virology|February 25, 2023
Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2Zinuo Chen, Ruikun Du, Laura Cooper, et al.
Viruses|December 31, 2025
Generation and Characterization of a CE1-Modified mCherry-Expressing Influenza A Virus for In Vivo Imaging and Antiviral Drug EvaluationZhenghao Li, Meiyi Liu, Jia Yang, et al.
Science Advances|February 23, 2024
An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxilIrina Gaisina, Ping Li, Ruikun Du, et al.
Antiviral Research|October 25, 2017
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virusRuikun Du, Lili Wang, Hao Xu, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
ACS Pharmacology & Translational Science|December 14, 2023
Identification of the Imidazo[1,2-<i>a</i>]pyrazine Derivative <b>A4</b> as a Potential Influenza Virus Nucleoprotein InhibitorPing Li, Han Ju, Yihong Xing, et al.
Experimental and Therapeutic Medicine|November 12, 2020
Selection and validation of optimal endogenous reference genes for analysis of quantitative PCR in four tissues pathologically associated with Kidney-yang deficiency syndrome following influenza A infectionYepei Fu, Jia Yang, Shanshan Fan, et al.
Cell & Bioscience|February 28, 2021
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteasesZinuo Chen, Qinghua Cui, Laura Cooper, et al.
Frontiers in Microbiology|April 8, 2020
Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase InhibitorsPing Li, Ruikun Du, Yanyan Wang, et al.
Antiviral Research|March 12, 2025
Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agentRuikun Du, Jiawen Sun, Chunlei Zhang, et al.
Journal of Medical Virology|August 28, 2023
Licochalcone A plays dual antiviral roles by inhibiting RSV and protecting against host damageZhongyuan Li, Baohong Li, Zinuo Chen, et al.
Journal of Medical Virology|February 25, 2023
Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2Zinuo Chen, Ruikun Du, Laura Cooper, et al.
Viruses|December 31, 2025
Generation and Characterization of a CE1-Modified mCherry-Expressing Influenza A Virus for In Vivo Imaging and Antiviral Drug EvaluationZhenghao Li, Meiyi Liu, Jia Yang, et al.
Science Advances|February 23, 2024
An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxilIrina Gaisina, Ping Li, Ruikun Du, et al.
Antiviral Research|October 25, 2017
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virusRuikun Du, Lili Wang, Hao Xu, et al.
Pageof 7